Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis

The aim of our study is to investigate patient selection for the 21-gene recurrence score assay (RS) for breast cancer (BC) and the RS impact on chemotherapy administration (Chemo) in clinical practice across the United States through the retrospective observational study of National Cancer Data Bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Orucevic, Amila, Heidel, Robert E., Bell, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903105/
https://www.ncbi.nlm.nih.gov/pubmed/27206678
http://dx.doi.org/10.1007/s10549-016-3833-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903105/
https://www.ncbi.nlm.nih.gov/pubmed/27206678
http://dx.doi.org/10.1007/s10549-016-3833-9

Ejemplares similares